Kamonwan Jutivorakool

1.5k total citations
21 papers, 602 citations indexed

About

Kamonwan Jutivorakool is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Kamonwan Jutivorakool has authored 21 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 7 papers in Infectious Diseases and 4 papers in Hepatology. Recurrent topics in Kamonwan Jutivorakool's work include Hepatitis Viruses Studies and Epidemiology (4 papers), Cytomegalovirus and herpesvirus research (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Kamonwan Jutivorakool is often cited by papers focused on Hepatitis Viruses Studies and Epidemiology (4 papers), Cytomegalovirus and herpesvirus research (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Kamonwan Jutivorakool collaborates with scholars based in Thailand, United States and Australia. Kamonwan Jutivorakool's co-authors include Sarah Browne, Li Ding, Steven M. Holland, Yingyos Avihingsanon, Lauren M. Yang, Lindsey B. Rosen, Alexandra F. Freeman, Suwasin Udomkarnjananun, Jakapat Vanichanan and John E. Bennett and has published in prestigious journals such as Blood, The Journal of Immunology and Scientific Reports.

In The Last Decade

Kamonwan Jutivorakool

21 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kamonwan Jutivorakool Thailand 10 377 260 179 70 51 21 602
Esther Benamu United States 9 230 0.6× 141 0.5× 133 0.7× 67 1.0× 28 0.5× 21 496
V. Boussaud France 18 305 0.8× 298 1.1× 51 0.3× 73 1.0× 101 2.0× 46 822
Alexander Wood United Kingdom 13 99 0.3× 101 0.4× 136 0.8× 26 0.4× 54 1.1× 19 545
Fabián Andrés Rosas Romero United States 8 242 0.6× 114 0.4× 70 0.4× 369 5.3× 44 0.9× 13 633
Giovanna Melica France 15 190 0.5× 222 0.9× 75 0.4× 38 0.5× 14 0.3× 51 682
Tarek Said Kuwait 13 195 0.5× 79 0.3× 48 0.3× 93 1.3× 106 2.1× 60 448
Pascale Frère Belgium 12 420 1.1× 370 1.4× 89 0.5× 271 3.9× 52 1.0× 24 739
Mathilde Lemoine France 11 119 0.3× 189 0.7× 56 0.3× 43 0.6× 120 2.4× 33 466
M. Stoffel Belgium 15 415 1.1× 129 0.5× 181 1.0× 83 1.2× 11 0.2× 24 730
Stefan Neuburger Germany 11 176 0.5× 145 0.6× 41 0.2× 138 2.0× 8 0.2× 14 502

Countries citing papers authored by Kamonwan Jutivorakool

Since Specialization
Citations

This map shows the geographic impact of Kamonwan Jutivorakool's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamonwan Jutivorakool with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamonwan Jutivorakool more than expected).

Fields of papers citing papers by Kamonwan Jutivorakool

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamonwan Jutivorakool. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamonwan Jutivorakool. The network helps show where Kamonwan Jutivorakool may publish in the future.

Co-authorship network of co-authors of Kamonwan Jutivorakool

This figure shows the co-authorship network connecting the top 25 collaborators of Kamonwan Jutivorakool. A scholar is included among the top collaborators of Kamonwan Jutivorakool based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamonwan Jutivorakool. Kamonwan Jutivorakool is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Vanichanan, Jakapat, et al.. (2021). Risk factors and clinical outcomes of tuberculosis among kidney transplant recipients in high endemic country. Transplant Infectious Disease. 23(3). e13566–e13566. 7 indexed citations
4.
Vanichanan, Jakapat, Roongruedee Chaiteerakij, Kamonwan Jutivorakool, et al.. (2021). A randomized controlled trial of comparative effectiveness between the 2 dose and 3 dose regimens of hepatitis a vaccine in kidney transplant recipients. Scientific Reports. 11(1). 50–50. 9 indexed citations
5.
Tungsanga, Somkanya, Pattama Torvorapanit, Suwasin Udomkarnjananun, et al.. (2020). A case of successful treatment of severe COVID‐19 pneumonia with favipiravir and tocilizumab in post–kidney transplant recipient. Transplant Infectious Disease. 23(1). e13388–e13388. 32 indexed citations
6.
Udomkarnjananun, Suwasin, et al.. (2020). Post-transplant Lymphoproliferative Disorder of Naso-orbital Region in Adult Renal Transplant Recipients: A Case Report and Literature Review. Transplantation Proceedings. 52(9). 2731–2735. 2 indexed citations
7.
8.
Udomkarnjananun, Suwasin, Natavudh Townamchai, Jakapat Vanichanan, et al.. (2019). Maximizing anti-HBs seroresponsiveness in kidney transplant waitlist patients: 
A tertiary-center perspective. Clinical Nephrology. 92(4). 190–200. 1 indexed citations
9.
Vanichanan, Jakapat, Suwasin Udomkarnjananun, Yingyos Avihingsanon, & Kamonwan Jutivorakool. (2018). Common viral infections in kidney transplant recipients. Kidney Research and Clinical Practice. 37(4). 323–337. 61 indexed citations
10.
Jutivorakool, Kamonwan, Cameron Hurst, Chanat Kumtornrut, et al.. (2018). Skin Manifestations in Patients with Adult-onset Immunodeficiency due to Anti-interferon-gamma Autoantibody: A Relationship with Systemic Infections. Acta Dermato Venereologica. 98(8). 742–747. 24 indexed citations
11.
Jutivorakool, Kamonwan, Cynthia E. Fisher, Robert M. Rakita, et al.. (2017). Comparison of Preemptive Therapy and Antiviral Prophylaxis for Prevention of Cytomegalovirus in Seropositive Liver Transplant Recipients. Transplantation. 102(4). 632–639. 7 indexed citations
12.
Townamchai, Natavudh, et al.. (2017). Prevalence of Hepatitis E Virus Infection Among Kidney Transplant Recipients in King Chulalongkorn Memorial Hospital, Thailand. Open Forum Infectious Diseases. 4(suppl_1). S728–S728. 2 indexed citations
13.
Pongpirul, Wannarat, Wiwat Chancharoenthana, Krit Pongpirul, et al.. (2016). B‐cell activating factor, a predictor of antibody mediated rejection in kidney transplantation recipients. Nephrology. 23(2). 169–174. 23 indexed citations
14.
Chiasakul, Thita, Natavudh Townamchai, Kamonwan Jutivorakool, et al.. (2015). Risk Factors of Cytomegalovirus Disease in Kidney Transplant Recipients: A Single-Center Study in Thailand. Transplantation Proceedings. 47(8). 2460–2464. 22 indexed citations
15.
Rosen, Lindsey B., Alexandra F. Freeman, Lauren M. Yang, et al.. (2013). Anti–GM-CSF Autoantibodies in Patients with Cryptococcal Meningitis. The Journal of Immunology. 190(8). 3959–3966. 177 indexed citations
16.
Browne, Sarah, Rifat Zaman, Elizabeth P. Sampaio, et al.. (2012). Anti-CD20 (rituximab) therapy for anti–IFN-γ autoantibody–associated nontuberculous mycobacterial infection. Blood. 119(17). 3933–3939. 124 indexed citations
17.
Jutivorakool, Kamonwan, et al.. (2011). Therapeutic effectiveness of a generic versus original meropenem in serious infections.. PubMed. 94(2). 172–8. 6 indexed citations
18.
Ding, Li, et al.. (2011). Determination of Human Anticytokine Autoantibody Profiles Using a Particle-Based Approach. Journal of Clinical Immunology. 32(2). 238–245. 41 indexed citations
19.
Suankratay, Chusana, Kamonwan Jutivorakool, & Supunnee Jirajariyavej. (2008). A prospective study of ceftriaxone treatment in acute pyelonephritis caused by extended-spectrum beta-lactamase-producing bacteria.. PubMed. 91(8). 1172–81. 17 indexed citations
20.
Jutivorakool, Kamonwan, et al.. (2006). Basal ganglia and brainstem encephalitis, optic neuritis, and radiculomyelitis in Epstein–Barr virus infection. Journal of Infection. 54(3). e141–e144. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esther Benamu Breakdown of academic impact, for papers by V. Boussaud Breakdown of academic impact, for papers by Alexander Wood Breakdown of academic impact, for papers by Fabián Andrés Rosas Romero Breakdown of academic impact, for papers by Giovanna Melica Breakdown of academic impact, for papers by Tarek Said Breakdown of academic impact, for papers by Pascale Frère Breakdown of academic impact, for papers by Mathilde Lemoine Breakdown of academic impact, for papers by M. Stoffel Breakdown of academic impact, for papers by Stefan Neuburger
Rankless by CCL
2026